(Q35748176)

English

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.

scientific article published on December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

Hans Lilja

4

0 references

author name string

Yue Cao

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ake Lundwall

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Virgil Gadaleanu

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Anders Bjartell

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

161

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

2053-2063

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Generation of multiple angiogenesis inhibitors by human pancreatic cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Expression and characterization of trypsinogen produced in the human male genital tract

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

The new human kallikrein gene family: implications in carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Production and activation of recombinant hK2 with propeptide mutations resulting in high expression levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Antiangiogenic activity of prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Prostatic human kallikrein 2 inactivates and complexes with plasminogen activator inhibitor-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Genetic aspects of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Antithrombin. A bloody important serpin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Purification of enzymatically active kallikrein hK2 from human seminal plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Primary structure of a human glandular kallikrein gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Small cell carcinoma of the lung: interaction with the blood coagulation mechanism and treatment with anticoagulants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Blood coagulation studies in patients with advanced carcinoma of the prostate treated with 2,6-cis-diphenylhexamethylcyclotetrasiloxane or estramustine-17-phosphate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

The Size and Shape of Human and Bovine Antithrombin III

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

12 July 2018

Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

25 September 2018

Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

25 September 2018

Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

25 September 2018

Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

25 September 2018

Mechanism of inactivation of trypsin by antithrombin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1850909

25 September 2018

Antithrombin-heparin cofactor: an inhibitor of plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Antithrombin III producing hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Occurrence of blood coagulation factors in situ in small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Antithrombin III and Factor VIII in Patients with Neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Estrogen-induced deficiency and decrease in antithrombin III activity in patients with prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Prostate antigen: A new potential marker for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

A simple two-step procedure for the isolation of antithrombin III from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Assignment of the human antithrombin III structural gene to chromosome 1q23-25

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Molecular genetics of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964484-7

7 January 2021

Kinetic characterization of the substrate reaction between a complex of antithrombin with a synthetic reactive-bond loop tetradecapeptide and four target proteinases of the inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/12466122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/12466122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin III profiles in malignancy, relationship primary tumors and metastatic sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/12466122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12466122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Effect of estrogen treatment on antithrombin III activity in patients with carcinoma of the prostate]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12466122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12466122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin

1 reference

https://pubmed.ncbi.nlm.nih.gov/12466122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0002-9440(10)64484-7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35748176&oldid=2047661467"